Rare diseases
Investigational molecules
Locations
Back to Slovenia5 clinical trials in Murska Sobota, Slovenia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SloveniaKlinicnaPreskusanja.si(opens in a new tab)Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
SloveniaStudy on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure
SloveniaStudy on the Safety and Effectiveness of Lutikizumab and Adalimumab for Adults with Moderate to Severe Ulcerative Colitis
SloveniaStudy on AVP-786 for Treating Agitation in Alzheimer's Dementia Patients
SloveniaLong-Term Safety Study of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
SloveniaThe busiest research cities in the country
What the registry says about research in the country
Research focusing on managing behavioral symptoms in Alzheimer's disease, particularly investigating new treatments for agitation in dementia patients. These trials aim to evaluate innovative therapeutic approaches for improving quality of life.
Studies emphasize patient safety and tolerability assessment of new therapeutic compounds.
Innovative clinical trials exploring combination therapies for heart failure patients. Research focuses on testing new drug combinations with empagliflozin to improve cardiovascular outcomes and reduce hospitalization rates.
Studies target patients with specific ejection fraction parameters to optimize treatment approaches.
Comprehensive research into treatments for inflammatory bowel conditions, including studies on both Ulcerative Colitis and Crohn's Disease. Trials evaluate new targeted therapies and biological treatments.
Focus on comparing effectiveness of new compounds with established treatments for moderate to severe cases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
